HHLA2
Basic information
Region (hg38): 3:108296529-108378285
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HHLA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 3 | 0 |
Variants in HHLA2
This is a list of pathogenic ClinVar variants found in the HHLA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-108351830-C-T | not specified | Likely benign (Nov 26, 2024) | ||
3-108351844-C-G | not specified | Uncertain significance (Jul 12, 2022) | ||
3-108351844-C-T | not specified | Likely benign (Oct 24, 2024) | ||
3-108353440-G-T | not specified | Uncertain significance (Mar 08, 2024) | ||
3-108353477-G-A | not specified | Likely benign (Aug 10, 2021) | ||
3-108353481-T-C | not specified | Uncertain significance (Sep 27, 2024) | ||
3-108353510-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
3-108353634-G-T | not specified | Uncertain significance (May 23, 2023) | ||
3-108355139-A-G | not specified | Uncertain significance (Nov 22, 2024) | ||
3-108355178-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
3-108355183-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
3-108355193-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
3-108355195-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
3-108355248-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
3-108355258-G-C | not specified | Uncertain significance (Jul 14, 2021) | ||
3-108355282-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
3-108355304-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
3-108355331-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
3-108355337-A-T | not specified | Uncertain significance (Dec 16, 2023) | ||
3-108355366-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
3-108355373-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
3-108357855-A-G | not specified | Uncertain significance (May 31, 2023) | ||
3-108357860-G-T | not specified | Uncertain significance (Mar 15, 2024) | ||
3-108357873-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
3-108357897-A-C | not specified | Uncertain significance (Aug 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HHLA2 | protein_coding | protein_coding | ENST00000357759 | 8 | 81757 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000173 | 0.877 | 124564 | 0 | 21 | 124585 | 0.0000843 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.573 | 194 | 218 | 0.891 | 0.0000111 | 2720 |
Missense in Polyphen | 25 | 31.888 | 0.784 | 394 | ||
Synonymous | 1.77 | 62 | 82.4 | 0.752 | 0.00000479 | 757 |
Loss of Function | 1.55 | 12 | 19.3 | 0.621 | 9.06e-7 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000651 | 0.0000646 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000730 | 0.000724 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000177 |
Middle Eastern | 0.000730 | 0.000724 |
South Asian | 0.000179 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Through interaction with TMIGD2, costimulates T-cells in the context of TCR-mediated activation. Enhances T-cell proliferation and cytokine production via an AKT-dependent signaling cascade. {ECO:0000269|PubMed:23784006}.;
Recessive Scores
- pRec
- 0.0708
Intolerance Scores
- loftool
- 0.844
- rvis_EVS
- 1.82
- rvis_percentile_EVS
- 96.99
Haploinsufficiency Scores
- pHI
- 0.0472
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.283
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- positive regulation of cytokine production;T cell costimulation;positive regulation of activated T cell proliferation;regulation of immune response;T cell receptor signaling pathway
- Cellular component
- cellular_component;external side of plasma membrane;integral component of membrane
- Molecular function
- molecular_function;signaling receptor binding;protein binding